Application no. and date | 15177140.9 (espacenet) (Federated) (European Patent Register), 20030320 | Patent/reg. no. and date | DK/EP 2962690, 20190116 | Publication date | 20160106 | Priority no. and date | US 366515 P, 20020320, US 438450 P, 20030107 | EP pub. no. and date |
EP 2962690 20160106 | Effective date | | Applicant/owner | Amgen (Europe) GmbH, Floor 6-8 Suurstoffi 22 Risch-Rotkreuz 6343, CH | Applicant ref. no. | P67782DK01 | Inventor | Man, Hon-wah, 27 Grant Way
Princeton, NJ 08540, US, GE, Chuansheng, 9 Breckenridge Court
Belle Mead, NJ 08502, US, Muller, George W., P.O. Box 3688
Rancho Santa Fe, CA 92067, US, SCHAFER, Peter H., 237 Monroe Avenue
Belle Mead, NJ 08502, US | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | Opponent | | IPC Class | A61K 31/4035 (2006.01) , A61P 35/00 (2006.01) , C07C 317/28 (2006.01) , C07D 209/48 (2006.01) | Title | (+)-2-[1-(3-ETHOXY-4-METHOXYPHENYL)-2-METHYLSULFONYLETHYL]-4-ACETYLAMINOISOINDOLIN-1,3-DION: FREMGANGSMÅDER TIL ANVENDELSE OG SAMMENSÆTNINGER DERAF | Int. application no. | | Int. publication no. | | Related patent (certificate) | CA 2019 00033 | Status | Ophævet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|